Suppression of reaginic antibodies with modified allergens. IV. Induction of suppressor T cells by conjugates of polyethylene glycol (PEG) and monomethoxy PEG with ovalbumin.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  International Archives of Allergy and Applied Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  PMID 6450171
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Suppression of reaginic antibodies with modified allergens. III. Preparation of tolerogenic conjugates of common allergens with monomethoxypolyethylene glycols of different molecular weights by the mixed anhydride method.

  1981cited by this paper
• Immunological tolerance to allergenic protein determinants: a therapeutic approach for selective inhibition of IgE antibody production.

  1979cited by this paper
• Immunological properties of conjugates of ragweed pollen antigen E with methoxypolyethylene glycol or a copolymer of D-glutamic acid and D- lysine

  1979cited by this paper
• Immunologic tolerance to allergenic protein determinants: properties of tolerance induced in mice treated with conjugates of protein and a synthetic copolymer of D-glutamic acid and D-lysine (D-GL).

  1979cited by this paper
• IgE-selective and antigen-specific unresponsiveness in mice. I. Induction of the unresponsiveness by administration of ovalbumin-pullulan conjugate.

  1979cited by this paper
• Mechanisms of Reaginic Hypersensitivity and IgE Antibody Response

  1978cited by this paper
• Suppression of reaginic antibodies.

  1978cited by this paper
• Suppression of reaginic antibodies with modified allergens. II. Abrogation of reaginic antibodies with allergens conjugated to polyethylene glycol.

  1978cited by this paper
• Suppression of reaginic antibodies with modified allergens. I. Reduction in allergenicity of protein allergens by conjugation to polyethylene glycol.

  1978cited by this paper
• IgE formation in the rat after infection with Nippostrongylus brasiliensis. II. Proliferation of IgE-bearing cells in neonatally thymectomized animals.

  1977cited by this paper
• Haplotype preference in lymphocyte differentiation. I. Development of haplotype-specific helper and suppressor activities in F1 hybrid-activated T cell populations.

  1977cited by this paper
• Specific enrichment of the suppressor T cell bearing I-J determinants: parallel functional and serological characterizations

  1977cited by this paper
• Preparation and immunochemical properties of methoxypolyethylene glycol-coupled and N-carboxymethylated derivatives of ragweed pollen allergen, antigen E.

  1977cited by this paper
• Reaginic antibody formation in the mouse. IX. Enhancement of suppressor and helper cell activities of primed spleen cells.

  1977cited by this paper
• Separation of helper T cells from suppressor T cells expressing different Ly components. II. Activation by antigen: after immunization, antigen-specific suppressor and helper activities are mediated by distinct T-cell subclasses

  1976cited by this paper
• Independent differentiative pathways of Ly1 and Ly23 subclasses of T cells. Experimental production of mice deprived of selected T-cell subclasses

  1976cited by this paper
• Hapten-specific IgE antibody responses in mice. VI. Selective enhancement of IgE antibody production by low doses of X-irradiation and by cyclophosphamide.

  1976cited by this paper
• Coexistence of helper and suppressor activities in carrier-primed spleen cells.

  1976cited by this paper
• Regulation of reaginic antibody formation in animals.

  1975cited by this paper
• PCA reactions with mouse antibodies in mice and rats.

  1975cited by this paper
• The role of macrophages in the generation of T-helper cells. II. The genetic control of the macrophage-T-cell interaction for helper cell induction with soluble antigens

  1975cited by this paper
• IgE antibody-specific abrogation of an established immune response in mice by modified antigens.

  1975cited by this paper
• Suppression of reaginic antibody formation. I. Induction of hapten-specific tolerance.

  1975cited by this paper
• Separation and Functional Analysis of Subpopulations of Lymphocytes Bearing Complement and Fc Receptors

  1975cited by this paper
• Separation of T and B lymphocytes by nylon wool columns: evaluation of efficacy by functional assays in vivo.

  1974cited by this paper
• Thymus dependence of reaginic antibody formation in mice.

  1973cited by this paper
• FUNCTION OF MACROPHAGES IN ANTIGEN RECOGNITION BY GUINEA PIG T LYMPHOCYTES

  1973cited by this paper
• CARRIER FUNCTION IN ANTI-HAPTEN IMMUNE RESPONSES

  1970cited by this paper

• Recombinant Fusion Allergens, Cry j 1 and Cry j 2 from Japanese Cedar Pollen, Conjugated with Polyethylene Glycol Potentiate the Attenuation of Cry j 1-Specific IgE Production in Cry j 1-Sensitized Mice and Japanese Cedar Pollen Allergen-Sensitized Monkeys

  2015cites this paper
• Peptide and protein delivery using new drug delivery systems.

  2013cites this paper
• NKT Ligand Conjugated Immunotherapy

  2010cites this paper
• Development of PEGylated mammalian urate oxidase as a therapy for patients with refractory gout

  2009cites this paper
• Alpha-galactosylceramide-driven immunotherapy for allergy.

  2008cites this paper
• PEGylation: an approach for drug delivery. A review.

  2008cites this paper
• Modification of red cell antigenic characteristics via covalent modification with branched poly (ethylene glycol)

  2006cites this paper
• Passive Protection against Anthrax by Using a High-Affinity Antitoxin Antibody Fragment Lacking an Fc Region

  2005cites this paper
• Engineering therapeutic antibody fragments targeting the anthrax toxin

  2005cites this paper
• Monomethoxypolyethylene glycol-modified cardiac myosin treatment blocks the active and passive induction of experimental autoimmune myocarditis.

  2004cites this paper
• Conjugates of ovalbumin and monomethoxypolyethylene glycol abolish late allergic responses and decrease IL-4 and IL-5 mRNA expression in the rat.

  2003cites this paper
• Reduced immunogenicity of beta-lactoglobulin by conjugation with carboxymethyl dextran differing in molecular weight.

  2001cites this paper
• On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.

  2001cites this paper
• Reduced immunogenicity of beta-lactoglobulin by conjugation with carboxymethyl dextran.

  2000cites this paper
• Functional changes in beta-lactoglobulin by conjugation with cationic saccharides.

  2000cites this paper
• T Cells of Mice Treated with mPEG-Myasthenogenic Peptide Conjugate are Involved in Protection against EAMG by Stimulating Lower Pathogenic Antibody Responses

  2000cites this paper
• Immunogenic and tolerogenic properties of monomethoxypoly(ethylene glycol) conjugated proteins.

  1999cites this paper
• Antibody responses to allergen Lol pIV are suppressed following adoptive transfer of B lymphocytes from the internal image anti-idiotypic antibody-treated mice.

  1995cites this paper
• Antigen-specific suppressor factors of noncytotoxic CD8+ suppressor T cells downregulate antibody responses also to unrelated antigens when the latter are presented as covalently linked adducts with the specific antigen.

  1993cites this paper
• Evaluation of Poly(vinyl alcohol) for Protein Tailoring: Improvements in Pharmacokinetic Properties of Superoxide Dismutase

  1993cites this paper
• The conjugation of proteins with polyethylene glycol and other polymers: Altering properties of proteins to enhance their therapeutic potential

  1993cites this paper
• Conjugation of Cu,Zn-superoxide dismutase with succinylated gelatin: pharmacological activity and cell-lubricating function.

  1993cites this paper
• The suppressive effect of gelatin‐conjugated superoxide dismutase on disease development and severity of collagen‐induced arthritis in mice

  1993cites this paper
• Characterization of suppressor T cell clones derived from a mouse tolerized with conjugates of ovalbumin and monomethoxypolyethylene glycol.

  1992cites this paper
• Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide.

  1992cites this paper
• The uses and properties of PEG-linked proteins.

  1992cites this paper
• The immunosuppressive effect of polyethylene glycol in a flush solution for rat liver transplantation.

  1992cites this paper
• IgG antibody response to polyethylene glycol-modified adenosine deaminase in patients with adenosine deaminase deficiency.

  1992cites this paper
• Downregulation of helper T cells by an antigen-specific monoclonal Ts factor.

  1991cites this paper
• Immunotherapy with monomethoxypolyethylene glycol modified allergens.

  1990cites this paper
• Cloned suppressor T cells derived from mice tolerized with conjugates of antigen and monomethoxypolyethylene glycol. Relationship between monoclonal T suppressor factor and the T cell receptor.

  1990cites this paper
• [Chemical modification of proteins with polyethylene glycol (PEG): approach to new protein drugs].

  1990cites this paper
• Control of the Biological Dispersion of Therapeutic Proteins

  1990cites this paper
• Biological Dispersion and the Design of Site-Specific Protein Therapeutic Systems

  1990cites this paper
• Down-regulation of secondary in vitro antibody responses by suppressor T cells of mice treated with a tolerogenic conjugate of ovalbumin and monomethoxypolyethylene glycol, OVA(mPEG)13.

  1989cites this paper
• Improvement of specific immunotherapy by human IgG and modified allergens

  1989cites this paper
• Application of PEG-enzyme and magnetite-PEG-enzyme conjugates for biotechnological processes

  1988cites this paper
• Site‐specific linkage of methotrexate to monoclonal antibodies using an intermediate carrier

  1988cites this paper
• Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase.

  1987cites this paper
• Induction of in vivo helper activity for murine antibody responses by macrophages pulsed with ovalbumin-monomethoxypolyethylene glycol (OA-mPEG) conjugates.

  1987cites this paper
• Synthesis, isolation, and characterization of conjugates of ovalbumin with monomethoxypolyethylene glycol using cyanuric chloride as the coupling agent.

  1987cites this paper
• Tolerance induction in mice by conjugates of monoclonal immunoglobulins and monomethoxypolyethylene glycol. Transfer of tolerance by T cells and by T cell extracts.

  1987cites this paper
• Split immunosuppression of contact cell-mediated and of IgE hypersensitivity responses to dinitrofluorobenzene in mice.

  1986cites this paper
• Allergenic extract immunotherapy.

  1986cites this paper
• Suppression of the anti‐hapten IgE antibody response with hapten‐modified spleen cells

  1986cites this paper
• Suppression of murine IgE responses with amino acid polymer/allergen conjugates. IV. Suppressive activities in established IgE model systems.

  1986cites this paper
• Suppression of murine IgE responses with amino acid polymer/allergen conjugates. III. Activity in vitro.

  1986cites this paper
• Immune responses to polyethylene glycol modified L-asparaginase in mice.

  1985cites this paper
• A double blind study on immunotherapy with chemically modified honey bee venom: monomethoxy polyethylene glycol-coupled versus crude honey bee venom.

  1985cites this paper
• Suppression of murine IgE responses with amino acid polymer/allergen conjugates. II. Suppressive activities in adjuvant-induced IgE responses.

  1985cites this paper
• Suppression of IgE antibody response against ovalbumin by the chemical conjugate of ovalbumin with a polyaspartic acid derivative.

  1985cites this paper
• Induction of tolerance in mice by uricase and monomethoxypolyethylene glycol-modified uricase.

  1984cites this paper
• Regulation of IgE synthesis.

  1984cites this paper
• IgE-binding factors from mouse T lymphocytes. III. Role of antigen-specific suppressor T cells in the formation of IgE-suppressive factor.

  1984cites this paper
• The Non‐Specific Enhancement of Allergy

  1983cites this paper
• Immunologie des Dünndarms

  1983cites this paper
• Idiotypic Regulation of the IgE Response

  1983cites this paper
• Antibodies against polyethylene glycol produced in animals by immunization with monomethoxy polyethylene glycol modified proteins.

  1983cites this paper
• Antibody responses to honey-bee venom and monomethoxy-polyethylene glycol-modified honey-bee venom in mice.

  1983cites this paper
• Regulation of the IgE antibody response by idiotype-anti-idiotype network.

  1982cites this paper
• Allergen immunotherapy with modified allergens

  1981cites this paper
• Suppression of reaginic antibodies with modified allergens. III. Preparation of tolerogenic conjugates of common allergens with monomethoxypolyethylene glycols of different molecular weights by the mixed anhydride method.

  1981cites this paper
• Suppression of IgE Antibodies with Tolerogenic Derivatives of Allergens

  1981cites this paper